KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Raw Materials (2016)

AbbVie has reported Raw Materials over the past 5 years, most recently at $132.0 million for Q2 2016.

  • Quarterly Raw Materials rose 4.76% to $132.0 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $132.0 million through Jun 2016, up 4.76% year-over-year, with the annual reading at $169.0 million for FY2015, 9.74% up from the prior year.
  • Raw Materials was $132.0 million for Q2 2016 at AbbVie, down from $155.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $261.0 million in Q4 2013 and troughed at $126.0 million in Q2 2015.
  • The 5-year median for Raw Materials is $163.0 million (2015), against an average of $188.2 million.
  • The largest YoY upside for Raw Materials was 9.74% in 2015 against a maximum downside of 45.02% in 2015.
  • A 5-year view of Raw Materials shows it stood at $258.0 million in 2012, then rose by 1.16% to $261.0 million in 2013, then tumbled by 41.0% to $154.0 million in 2014, then increased by 9.74% to $169.0 million in 2015, then fell by 21.89% to $132.0 million in 2016.
  • Per Business Quant, the three most recent readings for ABBV's Raw Materials are $132.0 million (Q2 2016), $155.0 million (Q1 2016), and $169.0 million (Q4 2015).